Novel Activity of a Synthetic Decapeptide Against Toxoplasma gondii Tachyzoites
The killer peptide KP is a synthetic decapeptide derived from the sequence of the variable region of a recombinant yeast killer toxin-like microbicidal single-chain antibody. KP proved to exert significant activities against diverse microbial and viral pathogens through different mechanisms of actio...
Saved in:
Published in | Frontiers in microbiology Vol. 9; p. 753 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
20.04.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The killer peptide KP is a synthetic decapeptide derived from the sequence of the variable region of a recombinant yeast killer toxin-like microbicidal single-chain antibody. KP proved to exert significant activities against diverse microbial and viral pathogens through different mechanisms of action, but little is known of its effect on apicomplexan protozoa. The aim of the present study was to evaluate the
activity of KP against
, a globally widespread protozoan parasite of great medical interest. The effect of KP treatment and its potential mechanism of action on
were evaluated by various methods, including light microscopy, quantitative PCR, flow cytometry, confocal microscopy, and transmission electron microscopy. In the presence of KP, the number of
tachyzoites able to invade Vero cells and the parasite intracellular proliferation were significantly reduced. Morphological observation and analysis of apoptotic markers suggested that KP is able to trigger an apoptosis-like cell death in
. Overall, our results indicate that KP could be a promising candidate for the development of new anti-
drugs with a novel mechanism of action. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Santi M. Mandal, Indian Institute of Technology Kharagpur, India Reviewed by: Yusuf Tutar, Istanbul University, Turkey; Esther Orozco, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology |
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2018.00753 |